This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lu, H. Articles by Graves, D. T. Search for Related Content PubMed PubMed Citation Articles by Lu, H. Articles by Graves, D. T.

Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation

Department of Periodontology and Oral Biology (H.L., D.K., D.T.G.), Boston University School of Dental Medicine, and Department of Orthopaedic Surgery (L.C.G.), Boston Medical Center, Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Dr. Dana T. Graves, Boston University School of Dental Medicine, Suite W-202D, 700 Albany Street, Boston, Massachusetts 02118. E-mail: dgraves{at}bu.edu.

Type 1 diabetes in humans has as one of its complications inadequate bone formation, resulting in osteopenia and delayed fracture healing. To investigate the mechanisms by which diabetes affects bone formation, experiments were performed in a marrow ablation model. Mice were made diabetic by multiple low-dose streptozotocin treatment, and controls were treated with vehicle alone. Killing occurred 0, 2, 4, 6, 10, and 16 d following marrow ablation. Histologic analysis demonstrated that the amount of immature mesenchymal tissue was equivalent in both the experimental and control groups on d 4. On d 6 a burst of bone formation occurred in the control group that was significantly reduced in the diabetic group. This deficit was evident at the molecular level as shown by diminished expression of osteocalcin, collagen types I. When transcription factors were examined, core-binding factor 1 (Cbfa1)/runt domain factor-2 (Runx-2) and human homolog of the drosophila distal-less gene (Dlx5) expression were substantially reduced in the diabetic, compared with control, groups on d 4 and 6. C-fos but not c-jun expression was also suppressed in the diabetic group but not closely linked to bone formation. Insulin treatment substantially reversed the effect of diabetes on the expression of bone matrix osteocalcin and collagen type I and transcription factors Cbfa1/Runx2 and Dlx5. These results indicate that diabetic animals produce sufficient amounts of immature mesenchymal tissue but fail to adequately express genes that regulate osteoblast differentiation, Cbfa1/Runx-2 and Dlx5, which in turn, leads to decreased bone formation.

This article has been cited by other articles:

				D. K. Wukich and A. J. Kline The Management of Ankle Fractures in Patients with Diabetes J. Bone Joint Surg. Am., July 1, 2008; 90(7): 1570 - 1578. [Abstract] [Full Text] [PDF]

				J. L. Fowlkes, R. C. Bunn, L. Liu, E. C. Wahl, H. N. Coleman, G. E. Cockrell, D. S. Perrien, C. K. Lumpkin Jr., and K. M. Thrailkill Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus Endocrinology, April 1, 2008; 149(4): 1697 - 1704. [Abstract] [Full Text] [PDF]

				S. B. Chaudhary, F. A. Liporace, A. Gandhi, B. G. Donley, M. S. Pinzur, and S. S. Lin Complications of Ankle Fracture in Patients With Diabetes J. Am. Acad. Ortho. Surg., March 1, 2008; 16(3): 159 - 170. [Abstract] [Full Text] [PDF]

				Z.S. AI-Aql, A.S. Alagl, D.T. Graves, L.C. Gerstenfeld, and T.A. Einhorn Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis J. Dent. Res., February 1, 2008; 87(2): 107 - 118. [Abstract] [Full Text] [PDF]

				K. Fulzele, D. J. DiGirolamo, Z. Liu, J. Xu, J. L. Messina, and T. L. Clemens Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action J. Biol. Chem., August 31, 2007; 282(35): 25649 - 25658. [Abstract] [Full Text] [PDF]

				U. Valcourt, B. Merle, E. Gineyts, S. Viguet-Carrin, P. D. Delmas, and P. Garnero Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation J. Biol. Chem., February 23, 2007; 282(8): 5691 - 5703. [Abstract] [Full Text] [PDF]

				S. Botolin and L. R. McCabe Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice Endocrinology, January 1, 2007; 148(1): 198 - 205. [Abstract] [Full Text] [PDF]

				R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone Endocrinology, December 1, 2006; 147(12): 5760 - 5767. [Abstract] [Full Text] [PDF]

				D.T. Graves, R. Liu, M. Alikhani, H. Al-Mashat, and P.C. Trackman Diabetes-enhanced Inflammation and Apoptosis--Impact on Periodontal Pathology J. Dent. Res., January 1, 2006; 85(1): 15 - 21. [Abstract] [Full Text] [PDF]

				N. Kloting, N. Follak, and I. Kloting Is there an autoimmune process in bone? Gene expression studies in diabetic and nondiabetic BB rats as well as BB rat-related and -unrelated rat strains Physiol Genomics, December 14, 2005; 24(1): 59 - 64. [Abstract] [Full Text] [PDF]

				K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E735 - E745. [Abstract] [Full Text] [PDF]

				K. M. Thrailkill, L. Liu, E. C. Wahl, R. C. Bunn, D. S. Perrien, G. E. Cockrell, R. A. Skinner, W. R. Hogue, A. A. Carver, J. L. Fowlkes, et al. Bone Formation Is Impaired in a Model of Type 1 Diabetes Diabetes, October 1, 2005; 54(10): 2875 - 2881. [Abstract] [Full Text] [PDF]

				S. Botolin, M.-C. Faugere, H. Malluche, M. Orth, R. Meyer, and L. R. McCabe Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-{gamma}2 Expression in Type I Diabetic Mice Endocrinology, August 1, 2005; 146(8): 3622 - 3631. [Abstract] [Full Text] [PDF]

				M. Qiao, P. Shapiro, R. Kumar, and A. Passaniti Insulin-like Growth Factor-1 Regulates Endogenous RUNX2 Activity in Endothelial Cells through a Phosphatidylinositol 3-Kinase/ERK-dependent and Akt-independent Signaling Pathway J. Biol. Chem., October 8, 2004; 279(41): 42709 - 42718. [Abstract] [Full Text] [PDF]

				H. He, R. Liu, T. Desta, C. Leone, L. C. Gerstenfeld, and D. T. Graves Diabetes Causes Decreased Osteoclastogenesis, Reduced Bone Formation, and Enhanced Apoptosis of Osteoblastic Cells in Bacteria Stimulated Bone Loss Endocrinology, January 1, 2004; 145(1): 447 - 452. [Abstract] [Full Text] [PDF]